L’American Society of Clinical Oncology ha condotto una revisione sistematica degli studi pertinenti e sviluppato raccomandazioni per la pratica clinica sulle terapie mirate per i pazienti con carcinoma gastroesofageo avanzato.
Scarica e leggi il full text dell’articolo:
- Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline
Manish A. Shah, Erin B. Kennedy, Ashley E. Alarcon-Rozas, Thierry Alcindor, Angela N. Bartley, Aubrey Belk Malowany, Nishin A. Bhadkamkar, Dana C. Deighton, Yelena Janjigian, Asha Karippot, Uqba Khan, Daniel A. King, Kelsey Klute, Jill Lacy, James J. Lee, Rutika Mehta, Sarbajit Mukherjee, Arun Nagarajan, Haeseong Park, Anwaar Saeed, Thomas J. Semrad, Kohei Shitara, Elizabeth Smyth, Natalia V. Uboha, Melani Vincelli, Zev Wainberg, and Lakshmi Rajdev
Journal of Clinical Oncology DOI: 10.1200/JCO.22.02331
